By the Numbers

PLS positioning into a bull steepening

| August 9, 2024

This document is intended for institutional investors and is not subject to all of the independence and disclosure standards applicable to debt research reports prepared for retail investors. This material does not constitute research.

The recent move in both rates and risk illustrated how different private label exposures may perform into a pronounced bull steepening of the yield curve. Shorter spread duration, more positively convex profiles such as RPL‘AAA’s and discount front sequentials and pass-throughs backed by agency-eligible investor loans appear poised to outperform against the backdrop of potentially elevated rate and spread volatility.

This latest drop in rates and sell off in risk had a disparate impact on different sectors of the private label market. Some sectors held up well against the volatility while others underperformed. Primary market spreads on deals backed by agency-eligible investor loans, scratch-and-dent collateral and residential transition loans fared better than deals backed by prime jumbo and non-QM loans. This week’s move impacted valuations in the secondary market as well. Spreads on premium cash flows, particularly more negatively convex 6.0% front sequentials backed by jumbo collateral and premium coupon non-QM ‘AAA’s experienced greater nominal spread widening than other exposures. In addition to a restriking of prepayment assumptions to faster speeds across these cohorts, investors are likely putting increased weighting on the probability that outstanding non-QM trusts backed by higher gross WAC collateral get called at the first 3-year optional redemption rather than the four year step-up pricing call.

Stacking up exposures

Modeling these cash flows broadly show that while all these exposures are generally short duration, they have varying degrees of negative convexity. Discount investor bonds, RPLs and scratch-and-dent ‘AAA’s by and large are less negatively convex and exhibit lower option cost than other short duration private label exposures. Investor 5.5% pass throughs and RPL ‘AAA’s carry the most base case duration at roughly 3.5 years. RPL ‘AAA’s are substantially less negatively convex than investor pass throughs despite being more structurally levered due to the modified, low WAC, highly seasoned nature of the collateral. Scratch and dent ‘AAA’s exhibit a similar convexity profile to RPLs even though these pools are generally collateralized by always performing loans which, for some reason or another, were either not deliverable to agency execution or were repurchased out of MBS trusts due to potential defects in underwriting.

Screening for Total Return

An analysis of these cash flows over instantaneous parallel and non-parallel shocks of the yield curve shows that in a 50 bp bull steepening of the yield curve, RPL AAA’s offer the best total return prospects. 5.5% pass throughs and front sequentials backed by investor collateral offer attractive total return as well (Exhibit 1). Based on the analytical framework, which hold OAS constant, non-QM AAAs appear to offer some of the best total return prospects. However, a bull steepening of the yield curve would be commensurate with lower front end benchmark rates. A re-steepening of the yield curve in this manner creates substantial incentive for sponsors of non-QM trusts to re-lever outstanding liabilities at the first call date given that the ‘AAA’ through ‘A’ rated pro-rata portion of the capital structure is struck off a two-year benchmark rate. As evidenced in price action this week, the pulling forward of callability assumptions should drive both nominal and option adjusted spread widening in these cash flows on premium bonds, capping dollar prices into a rally, which is not reflected using a constant OAS framework.

Exhibit 1: Total return across PLS exposures

Source: Santander US Capital Markets, YieldBook as of 8/8/24 closing curve and end-of-day pricing.

Leveling the playing field.

While illustrative to look at on a stand-alone basis, clearly longer duration exposures will have the advantage of greater price appreciation into a rally than shorter ones. Given this, all exposures are normalized on a duration- and proceeds-neutral basis to a 2.5-year base case effective duration. Exposures with modeled durations shorter than 2.5 years are combined with a basket of 10-year Treasury notes to achieve equivalent duration. Conversely, exposures with longer durations are combined with one-month Treasury bills to normalized duration.

Upon normalizing for both duration and proceeds, RPL ‘AAA’s and both longer front sequential cuts and pass-throughs with 5.5% coupons backed by agency-eligible investor collateral offer the highest total return into a bull steepening of the yield curve (Exhibit 2). These bonds also offer a total return advantage over other exposures to parallel shifts lower in rates. Jumbo transaction that priced this week have shown some spread widening versus deals backed by investor collateral. However, it appears that the convexity afforded to investors in the form of both far lower average loan size than jumbo as well as a substantially more lagged response to refinancing incentive in investor collateral is still mispriced to some degree. Given this, the potential for total return from these cash flows may be even better than forecasted if demand for call protection increases and spreads tighten across these bonds.

Exhibit 2: RPL, investor outperform into a bull steepening

Source: Santander US Capital Markets, YieldBook as of 8/8/24 closing curve and end-of-day pricing.

Chris Helwig
christopher.helwig@santander.us
1 (646) 776-7872

This material is intended only for institutional investors and does not carry all of the independence and disclosure standards of retail debt research reports. In the preparation of this material, the author may have consulted or otherwise discussed the matters referenced herein with one or more of SCM’s trading desks, any of which may have accumulated or otherwise taken a position, long or short, in any of the financial instruments discussed in or related to this material. Further, SCM may act as a market maker or principal dealer and may have proprietary interests that differ or conflict with the recipient hereof, in connection with any financial instrument discussed in or related to this material.

This message, including any attachments or links contained herein, is subject to important disclaimers, conditions, and disclosures regarding Electronic Communications, which you can find at https://portfolio-strategy.apsec.com/sancap-disclaimers-and-disclosures.

Important Disclaimers

Copyright © 2024 Santander US Capital Markets LLC and its affiliates (“SCM”). All rights reserved. SCM is a member of FINRA and SIPC. This material is intended for limited distribution to institutions only and is not publicly available. Any unauthorized use or disclosure is prohibited.

In making this material available, SCM (i) is not providing any advice to the recipient, including, without limitation, any advice as to investment, legal, accounting, tax and financial matters, (ii) is not acting as an advisor or fiduciary in respect of the recipient, (iii) is not making any predictions or projections and (iv) intends that any recipient to which SCM has provided this material is an “institutional investor” (as defined under applicable law and regulation, including FINRA Rule 4512 and that this material will not be disseminated, in whole or part, to any third party by the recipient.

The author of this material is an economist, desk strategist or trader. In the preparation of this material, the author may have consulted or otherwise discussed the matters referenced herein with one or more of SCM’s trading desks, any of which may have accumulated or otherwise taken a position, long or short, in any of the financial instruments discussed in or related to this material. Further, SCM or any of its affiliates may act as a market maker or principal dealer and may have proprietary interests that differ or conflict with the recipient hereof, in connection with any financial instrument discussed in or related to this material.

This material (i) has been prepared for information purposes only and does not constitute a solicitation or an offer to buy or sell any securities, related investments or other financial instruments, (ii) is neither research, a “research report” as commonly understood under the securities laws and regulations promulgated thereunder nor the product of a research department, (iii) or parts thereof may have been obtained from various sources, the reliability of which has not been verified and cannot be guaranteed by SCM, (iv) should not be reproduced or disclosed to any other person, without SCM’s prior consent and (v) is not intended for distribution in any jurisdiction in which its distribution would be prohibited.

In connection with this material, SCM (i) makes no representation or warranties as to the appropriateness or reliance for use in any transaction or as to the permissibility or legality of any financial instrument in any jurisdiction, (ii) believes the information in this material to be reliable, has not independently verified such information and makes no representation, express or implied, with regard to the accuracy or completeness of such information, (iii) accepts no responsibility or liability as to any reliance placed, or investment decision made, on the basis of such information by the recipient and (iv) does not undertake, and disclaims any duty to undertake, to update or to revise the information contained in this material.

Unless otherwise stated, the views, opinions, forecasts, valuations, or estimates contained in this material are those solely of the author, as of the date of publication of this material, and are subject to change without notice. The recipient of this material should make an independent evaluation of this information and make such other investigations as the recipient considers necessary (including obtaining independent financial advice), before transacting in any financial market or instrument discussed in or related to this material.

Important disclaimers for clients in the EU and UK

This publication has been prepared by Trading Desk Strategists within the Sales and Trading functions of Santander US Capital Markets LLC (“SanCap”), the US registered broker-dealer of Santander Corporate & Investment Banking. This communication is distributed in the EEA by Banco Santander S.A., a credit institution registered in Spain and authorised and regulated by the Bank of Spain and the CNMV. Any EEA recipient of this communication that would like to affect any transaction in any security or issuer discussed herein should do so with Banco Santander S.A. or any of its affiliates (together “Santander”). This communication has been distributed in the UK by Banco Santander, S.A.’s London branch, authorised by the Bank of Spain and subject to regulatory oversight on certain matters by the Financial Conduct Authority (FCA) and the Prudential Regulation Authority (PRA).

The publication is intended for exclusive use for Professional Clients and Eligible Counterparties as defined by MiFID II and is not intended for use by retail customers or for any persons or entities in any jurisdictions or country where such distribution or use would be contrary to local law or regulation.

This material is not a product of Santander´s Research Team and does not constitute independent investment research. This is a marketing communication and may contain ¨investment recommendations¨ as defined by the Market Abuse Regulation 596/2014 ("MAR"). This publication has not been prepared in accordance with legal requirements designed to promote the independence of research and is not subject to any prohibition on dealing ahead of the dissemination of investment research. The author, date and time of the production of this publication are as indicated herein.

This publication does not constitute investment advice and may not be relied upon to form an investment decision, nor should it be construed as any offer to sell or issue or invitation to purchase, acquire or subscribe for any instruments referred herein. The publication has been prepared in good faith and based on information Santander considers reliable as of the date of publication, but Santander does not guarantee or represent, express or implied, that such information is accurate or complete. All estimates, forecasts and opinions are current as at the date of this publication and are subject to change without notice. Unless otherwise indicated, Santander does not intend to update this publication. The views and commentary in this publication may not be objective or independent of the interests of the Trading and Sales functions of Santander, who may be active participants in the markets, investments or strategies referred to herein and/or may receive compensation from investment banking and non-investment banking services from entities mentioned herein. Santander may trade as principal, make a market or hold positions in instruments (or related derivatives) and/or hold financial interest in entities discussed herein. Santander may provide market commentary or trading strategies to other clients or engage in transactions which may differ from views expressed herein. Santander may have acted upon the contents of this publication prior to you having received it.

This publication is intended for the exclusive use of the recipient and must not be reproduced, redistributed or transmitted, in whole or in part, without Santander’s consent. The recipient agrees to keep confidential at all times information contained herein.

The Library

Search Articles